This department is offering this grant to provide continued support for research activities aimed at advancing clinical interventions for HIV-associated malignancies, improving therapeutics, studying the biology of HIV malignancies, addressing international issues in HIV-associated malignancies, and contributing to ongoing investigations. The grant seeks to fund the ANCHOR study on the treatment of anal cancer HSIL. The Consortium will include a coordinating center, clinical trials sites, network laboratories, and a statistical center, with multiple scientific disease-oriented Working Groups dedicated to specific cancer types. Closing date for applications is Jan 06, 2015.
Opportunity ID: 261474
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-14-502 |
| Funding Opportunity Title: | Limited Competition: AIDS Malignancy Clinical Trials Consortium (UM1) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 08, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 06, 2015 |
| Current Closing Date for Applications: | Jan 06, 2015 |
| Archive Date: | Feb 06, 2015 |
| Estimated Total Program Funding: | $21,400,000 |
| Award Ceiling: | $21,400,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Only the current awardees of the AIDS Malignancy Consortium are eligible to apply to this FOA. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this limited competition funding opportunity announcement (FOA) is to continue support of the research activities of the AIDS Malignancy Consortium which are: 1) design, development, and evaluation of clinical interventions for the prevention and treatment of malignancies in patients with HIV infection; 2) development of more effective management and therapeutics for HIV-associated malignancies; 3) investigation of the biology of HIV malignancies within the context of clinical trials; 4) management of issues of international importance in HIV-associated-malignancies; and 5) distribution of excess tumor tissue and other relevant biologic fluids to the AIDS and Cancer Specimen Resource for ongoing or future investigations. In addition, the AMC is expected to continue the development and execution of the “ANCHOR” study on the treatment of anal cancer high-grade squamous intraepithelial lesions (HSIL) to reduce anal cancer. In the current funding period, the initiation of the ANCHOR study was supported through supplemental funding to AMC.
The Consortium will consist of a coordinating center, clinical trials sites, network laboratories, and a statistical center. The Consortium will have at least four scientific disease-oriented Working Groups (WGs): 1) Kaposi sarcoma WG; 2) lymphoma WG; 3) WG for human papilloma virus-associated cancers; and 4) WG for non-AIDS-Defining Cancers. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-14-502.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | FORMS-C | PKG00202825 | Dec 06, 2014 | Jan 06, 2015 | View |
Package 1
Mandatory forms
261474 RR_SF424_2_0-2.0.pdf
261474 PHS398_ResearchPlan_2_0-2.0.pdf
261474 PHS398_CoverPageSupplement_2_0-2.0.pdf
261474 RR_Budget_1_3-1.3.pdf
261474 RR_KeyPersonExpanded_2_0-2.0.pdf
261474 RR_OtherProjectInfo_1_3-1.3.pdf
261474 PerformanceSite_2_0-2.0.pdf
Optional forms
261474 PlannedReport-1.0.pdf
261474 PHS398_CumulativeInclusionReport-1.0.pdf
261474 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
